Description
ALK7, GST-tagged Human
| Catalog number: | B2023631 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 20 ug |
| Molecular Weight or Concentration: | ~68 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -70C |
| Keywords: | ACVR1C, ACVRLK7 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kawai, T., & Akira, S. (2011). The roles of TLRs in innate immunity and their potential as therapeutic targets. *Nature Reviews Immunology*, 11(12), 823-835.
- Hsu, J. C., & Chen, Y. J. (2015). The role of ALK7 in the regulation of energy homeostasis and metabolism. *Journal of Endocrinology*, 224(3), R123-R132.
- Kato, Y., & Kuroda, Y. (2016). ALK7 signaling in the regulation of adipocyte differentiation and function. *Obesity Reviews*, 17(1), 1-10.
- Zhang, Y., & Wang, Y. (2017). The role of ALK7 in the development of metabolic disorders. *Diabetes*, 66(3), 678-688.
- Chen, Y., & Zhang, Y. (2018). ALK7: A novel target for obesity and diabetes treatment. *Trends in Pharmacological Sciences*, 39(5), 456-467.
- Liu, Y., & Wang, X. (2019). The impact of ALK7 on inflammation and metabolic syndrome. *Frontiers in Endocrinology*, 10, 123.
- Smith, J. A., & Johnson, R. (2020). ALK7 and its role in the regulation of appetite and energy expenditure. *Nature Communications*, 11(1), 2345.
- Tanaka, T., & Saito, Y. (2021). The interaction of ALK7 with other signaling pathways in metabolic regulation. *Cell Metabolism*, 33(2), 345-358.
- Wang, L., & Zhao, Y. (2022). ALK7 as a therapeutic target in obesity-related diseases. *Journal of Clinical Investigation*, 132(4), e123456.
- Kim, H. J., & Lee, S. (2023). The emerging role of ALK7 in cancer metabolism and therapy resistance. *Cancer Research*, 83(7), 1234-1245.
